These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 25234411)

  • 1. Survival rates and prognostic factors of Epstein-Barr virus-associated hydroa vacciniforme and hypersensitivity to mosquito bites.
    Miyake T; Yamamoto T; Hirai Y; Otsuka M; Hamada T; Tsuji K; Morizane S; Suzuki D; Aoyama Y; Iwatsuki K
    Br J Dermatol; 2015 Jan; 172(1):56-63. PubMed ID: 25234411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus reactivation is induced, but abortive, in cutaneous lesions of systemic hydroa vacciniforme and hypersensitivity to mosquito bites.
    Yamamoto T; Hirai Y; Miyake T; Hamada T; Yamasaki O; Morizane S; Fujimoto W; Iwatsuki K
    J Dermatol Sci; 2016 Jun; 82(3):153-9. PubMed ID: 27039668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroa vacciniforme is associated with increased numbers of Epstein-Barr virus-infected γδT cells.
    Hirai Y; Yamamoto T; Kimura H; Ito Y; Tsuji K; Miyake T; Morizane S; Suzuki D; Fujii K; Iwatsuki K
    J Invest Dermatol; 2012 May; 132(5):1401-8. PubMed ID: 22297643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroa vacciniforme: a distinctive form of Epstein-Barr virus-associated T-cell lymphoproliferative disorders.
    Iwatsuki K; Miyake T; Hirai Y; Yamamoto T
    Eur J Dermatol; 2019 Feb; 29(1):21-28. PubMed ID: 30998212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
    Iwatsuki K; Satoh M; Yamamoto T; Oono T; Morizane S; Ohtsuka M; Xu ZG; Suzuki D; Tsuji K
    Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The aim of the measurement of Epstein-Barr virus DNA in hydroa vacciniforme and hypersensitivity to mosquito bites.
    Miyake T; Iwatsuki K; Hirai Y; Yamamoto T; Hamada T; Fujii K; Imamura H; Morizane S
    J Med Virol; 2020 Dec; 92(12):3689-3696. PubMed ID: 32255500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel, noninvasive diagnostic probe for hydroa vacciniforme and related disorders: detection of latency-associated Epstein-Barr virus transcripts in the crusts.
    Yamamoto T; Tsuji K; Suzuki D; Morizane S; Iwatsuki K
    J Microbiol Methods; 2007 Feb; 68(2):403-7. PubMed ID: 17141343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of mortality in hydroa vacciniforme and hypersensitivity to mosquito bites.
    Poligone B
    Br J Dermatol; 2015 Jan; 172(1):5-6. PubMed ID: 25581582
    [No Abstract]   [Full Text] [Related]  

  • 9. Oculomucosal and gastrointestinal involvement in Epstein-Barr virus-associated hydroa vacciniforme.
    Yamamoto T; Hirai Y; Miyake T; Yamasaki O; Morizane S; Iwatsuki K
    Eur J Dermatol; 2012; 22(3):380-3. PubMed ID: 22361979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+ T-lymphocyte-induced Epstein-Barr virus reactivation in a patient with severe hypersensitivity to mosquito bites and Epstein-Barr virus-infected NK cell lymphocytosis.
    Asada H; Miyagawa S; Sumikawa Y; Yamaguchi Y; Itami S; Suguri S; Harada M; Tokura Y; Ishihara S; Ohshima S; Yoshikawa K
    Arch Dermatol; 2003 Dec; 139(12):1601-7. PubMed ID: 14676078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypersensitivity to mosquito bites and hydroa vacciniforme].
    Iwatsuki K; Yamamoto T; Tsuji K
    Nihon Rinsho; 2006 Mar; 64 Suppl 3():657-61. PubMed ID: 16615554
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypersensitivity to mosquito bites with natural-killer cell lymphocytosis: the possible implication of Epstein-Barr virus reactivation.
    Satoh M; Oyama N; Akiba H; Ohtsuka M; Iwatsuki K; Kaneko F
    Eur J Dermatol; 2002; 12(4):381-4. PubMed ID: 12095889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypersensitivity to mosquito bites: A versatile Epstein-Barr virus disease with allergy, inflammation, and malignancy.
    Yamada M; Ishikawa Y; Imadome KI
    Allergol Int; 2021 Oct; 70(4):430-438. PubMed ID: 34334322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases.
    Guo N; Chen Y; Wang Y; Huang Y; Feng Y; Li M; Rao H
    Diagn Pathol; 2019 Jul; 14(1):82. PubMed ID: 31315684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder.
    Lee HY; Baek JO; Lee JR; Park SH; Jeon IS; Roh JY
    Am J Dermatopathol; 2012 Dec; 34(8):e119-24. PubMed ID: 23169419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroa vacciniforme and hydroa vacciniforme-like T-cell lymphoma: an uncommon event for transformation.
    Chen CC; Chang KC; Medeiros LJ; Lee JY
    J Cutan Pathol; 2016 Dec; 43(12):1102-1111. PubMed ID: 27531667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Delayed diagnosis of hydroa vacciniforme-like lymphoproliferative disorder in a patient with skin rashes].
    Umeki Y; Ikeda M; Nakahara W; Asako M; Matsuoka Y; Terakawa T; Matsunaga H; Tadokoro R; Sekiguchi M; Matsui T; Oka K; Higuchi K; Sawada A; Inoue M; Ueda S
    Rinsho Ketsueki; 2023; 64(3):209-213. PubMed ID: 37019675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus-associated lymphoproliferative lesions presenting as a hydroa vacciniforme-like eruption: an analysis of six cases.
    Cho KH; Lee SH; Kim CW; Jeon YK; Kwon IH; Cho YJ; Lee SK; Suh DH; Chung JH; Yoon TY; Lee SJ
    Br J Dermatol; 2004 Aug; 151(2):372-80. PubMed ID: 15327544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and disease severity determination criteria for hydroa vacciniforme lymphoproliferative disorders and severe mosquito bite allergy.
    Hirai Y; Asada H; Hamada T; Kawada JI; Kimura H; Arai A; Ohshima K; Ohga S; Iwatsuki K;
    J Dermatol; 2023 Jul; 50(7):e198-e205. PubMed ID: 37249004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications.
    Paik JH; Choe JY; Kim H; Lee JO; Kang HJ; Shin HY; Lee DS; Heo DS; Kim CW; Cho KH; Kim TM; Jeon YK
    Leuk Lymphoma; 2017 Jan; 58(1):53-63. PubMed ID: 27157296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.